investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The Role of Cyclin E in Growth Control and Tumorogenesis
Steven I Reed
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Steven I Reed
Scripps Research Institute
San Diego, United States
Related projects
Chandra Bartholomeusz
Development of Targeted Therapy for ERK Pathway in Breast Cancer
Breast
Robert I Benezra
The Role of Endothelial Progenitor Cells in Tumor Growth and Metastasis
Breast
Munira Basrai
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
Breast
Kinam Park
Adaptable Polymer Micelles for Tumor Targeting
Breast
Matthew Bogyo
Chemical Probes for Specific Targeting of Matrix Metallo Proteases
Breast
Joshua Labaer
Biomarker Detection Using NAPPA Tumor Antigen Arrays
Breast
Lali K Medina-Kauwe
Tumor Targeted Corroles for Detection and Intervention
Breast
Maria Jasin
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES
Breast
William J Murphy
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
Breast
